Outlook Therapeutics Balance Sheet (2015-2026) | OTLK

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	19.69M	14.48M	70.15M	58.42M	26.02M	17.40M	52.34M	43.63M	33.71M	23.39M	10.36M	47.23M	32.02M	14.93M	5.70M	7.56M	8.90M	8.08M	8.68M	7.75M
Cash & Current Investments (Quarter)	19.69M	14.48M	70.15M	58.42M	26.02M	17.40M	52.34M	43.63M	33.71M	23.39M	10.36M	47.23M	32.02M	14.93M	5.70M	7.56M	8.90M	8.08M	8.68M	7.75M
Receivables - Net (Quarter)																	1.75M	1.49M	0.11M	2.72M
Receivables - Other (Quarter)
Receivables (Quarter)																	1.75M	1.49M	0.11M	2.72M
Raw Materials (Quarter)																		2.35M	2.35M	2.34M
Work In Process (Quarter)																0.27M	3.75M	0.96M	1.11M	0.80M
Finished Goods (Quarter)																3.33M	0.38M	0.03M		0.20M
Inventory (Quarter)															3.11M	3.60M	4.13M	3.34M	3.46M	3.34M
Prepaid Assets (Quarter)	12.21M	7.03M	7.32M	8.12M	11.49M	10.12M	9.34M	9.42M	9.31M	7.59M	10.03M	10.56M	13.59M	12.49M	6.86M	6.65M	6.32M	4.48M	4.92M	7.09M
Current Assets (Quarter)	31.90M	21.51M	77.47M	66.55M	37.51M	27.52M	61.68M	53.05M	43.02M	30.98M	20.39M	57.79M	45.62M	27.42M	15.67M	17.81M	21.10M	17.39M	17.17M	20.90M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	0.20M	0.16M	0.12M	0.08M	0.04M
Long-Term Investments (Quarter)	0.46M	0.85M	0.83M	0.82M	0.81M	0.80M	0.83M	0.81M	0.80M	0.79M	0.80M	0.77M	0.71M	0.69M	0.66M	0.62M	0.59M	0.55M	0.51M	0.47M
Other Non-Current Assets (Quarter)	0.19M	0.17M	0.16M	0.14M	0.14M	0.13M	0.13M	0.11M	0.59M	0.50M	0.48M	0.47M	0.48M	0.44M	0.42M	0.39M	0.46M	0.42M	0.35M	0.32M
Non-Current Assets (Quarter)	0.98M	1.30M	1.21M	1.14M	1.07M	1.01M	1.01M	0.97M	1.43M	1.32M	1.30M	1.24M	1.47M	1.41M	1.34M	1.27M	1.30M	1.20M	1.07M	0.99M
Assets (Quarter)	32.88M	22.81M	78.68M	67.69M	38.59M	28.53M	62.69M	54.02M	44.45M	32.30M	21.68M	59.03M	47.09M	28.82M	17.01M	19.08M	22.39M	18.58M	18.24M	21.89M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	2.67M	2.20M	2.55M	4.16M	2.48M	3.49M	4.17M	3.62M	5.06M	6.57M	3.48M	4.36M	5.55M	7.97M	12.19M	7.77M	10.26M	10.19M	7.32M	13.64M
Notes Payables (Quarter)	11.55M	0.90M	12.72M	22.78M	10.46M	10.92M		31.82M	34.73M	35.55M	36.54M	44.74M	32.43M	29.44M	30.74M	12.00M	14.00M	29.95M	36.66M	9.85M
Payables (Quarter)	14.22M	3.10M	15.26M	26.94M	12.94M	14.41M	4.17M	35.44M	39.79M	42.13M	40.02M	49.11M	37.98M	37.41M	42.94M	19.77M	24.26M	40.14M	43.98M	23.48M
Accumulated Expenses (Quarter)	0.01M	0.75M	223.00	2.55M	1.32M	1.98M	2.75M	1.66M	8.28M	2.75M	1.11M	3.12M	0.90M	1.01M	0.68M	0.57M	5.31M	1.59M	1.55M	0.72M
Other Accumulated Expenses (Quarter)	2.84M	0.81M	0.15M	1.15M	0.21M	0.14M	1.23M	3.84M	5.33M	1.23M	1.63M	0.54M	0.28M	0.38M	0.06M	0.32M	0.88M	1.19M	0.36M	0.19M
Short term Debt (Quarter)																				6.00M
Current Leases (Quarter)	0.03M	0.04M	0.02M	0.05M	0.04M	0.03M	0.01M	0.01M	0.01M	0.00M	0.00M		0.03M	0.05M	0.05M	0.05M	0.06M	0.06M	0.06M	0.06M
Current Taxes (Quarter)	1.86M	1.86M	1.86M	1.86M	1.86M	1.86M	1.86M	1.86M	1.86M	1.86M	1.86M	1.86M	1.86M	1.86M	1.86M	1.86M	1.86M	0.30M	0.30M	0.30M
Current Deferred Revenue (Quarter)
Total Current Liabilities (Quarter)	19.64M	6.75M	19.95M	31.41M	18.43M	19.73M	15.08M	43.53M	49.93M	46.73M	45.97M	54.08M	42.55M	42.55M	48.24M	24.82M	31.49M	45.81M	49.06M	38.88M
Non-Current Liabilities
Capital Leases (Quarter)	0.02M	0.02M	0.01M	0.01M	0.01M	0.00M	0.00M
Non-Current Debt (Quarter)		10.89M	9.60M				31.82M									21.05M	20.44M			11.12M
Non-Current Deffered Revenue (Quarter)
Preferred Stock Liabilities (Quarter)
Minority Interest (Quarter)
Operating Leases (Quarter)	0.08M	0.03M	0.02M	0.05M	0.04M	0.03M	0.02M	0.00M					0.26M	0.25M	0.23M	0.22M	0.20M	0.19M	0.17M	0.16M
Other Non-Current Liabilities (Quarter)	0.43M	0.52M	0.27M	0.30M	0.07M	0.06M	0.03M	0.01M	0.02M	0.01M	0.06M	139.18M	87.95M	59.10M	18.83M	5.45M	7.45M	4.77M	7.56M	0.72M
Total Non-Current Liabilities (Quarter)	19.70M	17.68M	29.58M	31.43M	18.44M	19.73M	46.90M	43.53M	49.93M	46.73M	45.97M	54.08M	42.81M	42.80M	48.47M	46.09M	52.13M	46.00M	49.23M	50.16M
Total Liabilities (Quarter)	20.13M	18.20M	29.85M	31.72M	18.51M	19.79M	46.93M	43.54M	49.95M	46.74M	46.03M	193.26M	130.77M	101.90M	67.30M	51.54M	59.58M	50.77M	56.79M	50.89M
Shareholder's Equity
Total Debt (Quarter)		10.89M	9.60M				31.82M									21.05M	20.44M			17.12M
Common Equity (Quarter)	12.75M	4.61M	48.82M	35.96M	20.08M	8.74M	15.76M	10.49M	-5.50M	-14.44M	-24.34M	-134.24M	-83.67M	-73.08M	-50.29M	-32.46M	-37.19M	-32.19M	-38.55M	-28.99M
Shareholder's Equity (Quarter)	12.75M	4.61M	48.82M	35.96M	20.08M	8.74M	15.76M	10.49M	-5.50M	-14.44M	-24.34M	-134.24M	-83.67M	-73.08M	-50.29M	-32.46M	-37.19M	-32.19M	-38.55M	-28.99M
Liabilities and Shareholders Equity (Quarter)	32.88M	22.81M	78.68M	67.69M	38.59M	28.53M	62.69M	54.02M	44.45M	32.30M	21.68M	59.03M	47.09M	28.82M	17.01M	19.08M	22.39M	18.58M	18.24M	21.89M
Retained Earnings (Quarter)	-329.48M	-342.88M	-357.35M	-377.05M	-394.59M	-408.94M	-427.60M	-434.25M	-454.93M	-467.92M	-479.10M	-593.39M	-548.98M	-543.28M	-525.91M	-572.26M	-592.42M	-605.71M	-628.77M	-633.22M
Preferred Shares (Quarter)
Treasury Shares (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	123.00	0.00M	123.00

Research Tools

Developers

Outlook Therapeutics Balance Sheet (2015-2026) | OTLK

Research Tools

Developers

Outlook Therapeutics Balance Sheet (2015-2026) | OTLK

Create an account

Sign In

Reset Password